Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 15 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Product containing precisely stavudine 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Product containing precisely stavudine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 37.5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 75mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Lamivudine 150 mg and stavudine 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Product containing lamivudine and stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Product containing lamivudine and nevirapine and stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Product containing stavudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine- and nevirapine- and stavudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 15 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 15 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 20 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Stavudine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Stavudine 30 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 40 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
2 |
Lamivudine 150 mg and stavudine 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
2 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
2 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
2 |
Stavudine 37.5mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 75mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 100mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Stavudine 50mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stavudine (substance) |
Inferred relationship |
Some |
|
Lamivudine 150 mg and stavudine 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Stavudine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely stavudine 15 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 20 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Stavudine 30 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely stavudine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Stavudine 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Stavudine 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine- and stavudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine and nevirapine and stavudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lamivudine and stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing only stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lamivudine and stavudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Stavudine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine and nevirapine and stavudine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Stavudine (substance) |
Inferred relationship |
Some |
1 |